Jacobs Levy Equity Management Inc. Makes New Investment in Agilent Technologies, Inc. $A

Key Points

• Jacobs Levy Equity Management Inc. has invested approximately $3.20 million in Agilent Technologies, acquiring 27,342 shares during the first quarter.
• Agilent reported $1.37 earnings per share for the last quarter, meeting analysts' expectations and showing a 10.1% increase in revenue compared to the previous year.
• Wall Street analysts have mixed ratings on Agilent Technologies, with six analysts rating it a "Buy" and a consensus price target of $139.25.

Jacobs Levy Equity Management Inc. acquired a new stake in Agilent Technologies, Inc. (NYSE:A - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 27,342 shares of the medical research company's stock, valued at approximately $3,198,000.

A number of other institutional investors and hedge funds have also made changes to their positions in A. Whipplewood Advisors LLC increased its position in shares of Agilent Technologies by 286.2% in the first quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock valued at $29,000 after buying an additional 186 shares in the last quarter. Sunbelt Securities Inc. raised its position in Agilent Technologies by 640.0% in the fourth quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock valued at $30,000 after purchasing an additional 192 shares during the period. Stone House Investment Management LLC purchased a new stake in Agilent Technologies in the first quarter valued at $30,000. Opal Wealth Advisors LLC purchased a new stake in shares of Agilent Technologies in the 1st quarter valued at $31,000. Finally, Wood Tarver Financial Group LLC purchased a new stake in shares of Agilent Technologies in the 4th quarter valued at $34,000. 87.41% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of the stock in a transaction that occurred on Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total transaction of $177,099.52. Following the completion of the sale, the chief executive officer directly owned 37,448 shares of the company's stock, valued at approximately $4,397,893.12. This trade represents a 3.87% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.26% of the company's stock.

Agilent Technologies Stock Down 2.8%

Shares of NYSE:A traded down $3.54 on Friday, hitting $123.19. 1,250,804 shares of the company's stock were exchanged, compared to its average volume of 1,689,851. The firm's 50-day moving average is $119.76 and its 200 day moving average is $115.87. The company has a market capitalization of $34.92 billion, a PE ratio of 28.92, a P/E/G ratio of 3.94 and a beta of 1.24. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.37. The business had revenue of $1.74 billion during the quarter, compared to analysts' expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The business's quarterly revenue was up 10.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Sell-side analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on A. Wells Fargo & Company boosted their price objective on Agilent Technologies from $135.00 to $140.00 and gave the company an "overweight" rating in a report on Thursday, August 28th. UBS Group cut their price objective on Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a report on Thursday, May 29th. JPMorgan Chase & Co. cut their price objective on Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a report on Thursday, May 29th. TD Cowen upped their price target on Agilent Technologies to $150.00 and gave the stock a "buy" rating in a report on Thursday, May 29th. Finally, Wall Street Zen downgraded Agilent Technologies from a "buy" rating to a "hold" rating in a report on Friday, September 5th. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $139.25.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.